A majority of participants (90.7%) who had been taking opioids and other pain medications were able to stop taking them or reduce their use.
Three medical cannabis companies have received fines that total almost $1 million (Australian dollars) from Australia’s drugs regulator.
The United States Pharmacopeia (USP) is in the process of adding Cannabis sativa to its list of herbal medicines and their properties.
The pre-proof study followed the habits of 77 licensed medical cannabis patients and found that shorter time gaps between cannabis use and sleep onset were associated with a lower likelihood of nightmares.
In a press conference on Thursday, September 22, Governor Andy Beshear told journalists that he had received a report from a medical cannabis advisory committee and “there will be some actions forthcoming.”
Regulators should take a closer look at the health risks presented by a growing cannabis market with no national-level guidance on contamination or pesticide use, a new study argues.
The new UK Cannabis Center will conduct research on the health effects of cannabis, “including its risks and benefits when used to treat certain medical conditions.”
The review was set to start last October, three years after Canada legalized recreational cannabis, but the process was delayed for unknown reasons.
Large increases in CHS emergency department visits were seen shortly following the wider market commercialization in Ontario, which included the opening of more retail stores and the sale of more diverse and potent products.